{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:58:06Z","timestamp":1782766686318,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012028","name":"Baystate Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12906-019-2506-8","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T15:00:10Z","timestamp":1557154810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Supplemental thiamine for the treatment of acute heart failure syndrome: a randomized controlled trial"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6972-5833","authenticated-orcid":false,"given":"Howard A.","family":"Smithline","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Donnino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidela S. J.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Barus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Coute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander B.","family":"Knee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Visintainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"key":"2506_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.09.011","volume":"119","author":"M Gheorghiade","year":"2006","unstructured":"Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006;119:S3\u2013S10.","journal-title":"Am J Med"},{"key":"2506_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev.ph.36.030174.002213","volume":"36","author":"JR Neely","year":"1974","unstructured":"Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol. 1974;36:413\u201359.","journal-title":"Annu Rev Physiol"},{"key":"2506_CR3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/CIRCULATIONAHA.106.613646","volume":"114","author":"CS Smith","year":"2006","unstructured":"Smith CS, Bottomley PA, Schulman SP, Gerstenblith G, Weiss RG. Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation. 2006;114:1151\u20138.","journal-title":"Circulation."},{"key":"2506_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1073\/pnas.0408962102","volume":"102","author":"RG Weiss","year":"2005","unstructured":"Weiss RG, Gerstenblith G, Bottomley PA. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A. 2005;102:808\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2506_CR5","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehi816","volume":"27","author":"G Fragasso","year":"2006","unstructured":"Fragasso G, et al. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine\/adenosine triphosphate ratio in patients with heart failure. Eur Heart J. 2006;27:942\u20138.","journal-title":"Eur Heart J"},{"key":"2506_CR6","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1161\/CIRCULATIONAHA.105.581819","volume":"112","author":"DA Morrow","year":"2005","unstructured":"Morrow DA, Givertz MM. Modulation of myocardial energetics: emerging evidence for a therapeutic target in cardiovascular disease. Circulation. 2005;112:3218\u201321.","journal-title":"Circulation."},{"key":"2506_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jacc.2005.08.060","volume":"47","author":"SA Hanninen","year":"2006","unstructured":"Hanninen SA, Darling PB, Sole MJ, Barr A, Keith ME. The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol. 2006;47:354\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"2506_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1006\/bbrc.1999.0321","volume":"256","author":"S Strumilo","year":"1999","unstructured":"Strumilo S, Czerniecki J, Dobrzyn P. Regulatory effect of thiamin pyrophosphate on pig heart pyruvate dehydrogenase complex. Biochem Biophys Res Commun. 1999;256:341\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"2506_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3177\/jnsv.20.35","volume":"20","author":"DJ Sutherland","year":"1974","unstructured":"Sutherland DJ, Jaussi AW, Gubler CJ. The effects of thiamine deprivation, and oxythiamine- and pyrithiamine-treatment on cardiac function and metabolism in the rat. J Nutr Sci Vitaminol (Tokyo). 1974;20:35\u201354.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"2506_CR10","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","volume":"95","author":"JLJ Januzzi","year":"2005","unstructured":"Januzzi JLJ, et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005;95:948\u201354.","journal-title":"Am J Cardiol"},{"key":"2506_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/eurheartj\/ehn048","volume":"29","author":"PS Pang","year":"2008","unstructured":"Pang PS, et al. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J. 2008;29:816\u201324.","journal-title":"Eur Heart J"},{"key":"2506_CR12","unstructured":"StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP; 2011. \n                    https:\/\/www.stata.com\/support\/faqs\/resources\/citing-software-documentation-faqs\/\n                    \n                  ."},{"key":"2506_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/eurjhf\/hfr173","volume":"14","author":"H Ardehali","year":"2012","unstructured":"Ardehali H, et al. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail. 2012;14:120\u20139.","journal-title":"Eur J Heart Fail"},{"key":"2506_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/hrt.2010.208751","volume":"97","author":"D Gao","year":"2011","unstructured":"Gao D, Ning N, Niu X, Hao G, Meng Z. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure. Heart. 2011;97:278\u201386.","journal-title":"Heart."},{"key":"2506_CR15","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11883-012-0265-9","volume":"14","author":"KS Heo","year":"2012","unstructured":"Heo KS, Fujiwara K, Abe J. Glucagon-like peptide-1 and its cardiovascular effects. Curr Atheroscler Rep. 2012;14:422\u20138.","journal-title":"Curr Atheroscler Rep"},{"key":"2506_CR16","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/CIRCRESAHA.111.253104","volume":"110","author":"WC Stanley","year":"2012","unstructured":"Stanley WC, Dabkowski ER, Ribeiro RFJ, O\u2019Connell KA. Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circ Res. 2012;110:764\u201376.","journal-title":"Circ Res"},{"key":"2506_CR17","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/0735-1097(94)90665-3","volume":"23","author":"RM Bersin","year":"1994","unstructured":"Bersin RM, et al. Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J Am Coll Cardiol. 1994;23:1617\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"2506_CR18","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","volume":"122","author":"K Abozguia","year":"2010","unstructured":"Abozguia K, et al. Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy. Circulation. 2010;122:1562\u20139.","journal-title":"Circulation."},{"key":"2506_CR19","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1136\/hrt.2011.226332","volume":"97","author":"G Fragasso","year":"2011","unstructured":"Fragasso G, et al. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure. Heart. 2011;97:1495\u2013500.","journal-title":"Heart."},{"key":"2506_CR20","doi-asserted-by":"publisher","first-page":"H1096","DOI":"10.1152\/ajpheart.00930.2009","volume":"298","author":"M Halbirk","year":"2010","unstructured":"Halbirk M, et al. Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure. Am J Physiol Heart Circ Physiol. 2010;298:H1096\u2013102.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2506_CR21","doi-asserted-by":"publisher","first-page":"H1220","DOI":"10.1152\/ajpheart.00475.2010","volume":"299","author":"M Halbirk","year":"2010","unstructured":"Halbirk M, et al. Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function. Am J Physiol Heart Circ Physiol. 2010;299:H1220\u20135.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2506_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-2143(99)90203-2","volume":"134","author":"J Rieck","year":"1999","unstructured":"Rieck J, et al. Urinary loss of thiamine is increased by low doses of furosemide in healthy volunteers. J Lab Clin Med. 1999;134:238\u201343.","journal-title":"J Lab Clin Med"},{"key":"2506_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00005082-200603000-00008","volume":"21","author":"TA Lennie","year":"2006","unstructured":"Lennie TA, Moser DK, Heo S, Chung ML, Zambroski CH. Factors influencing food intake in patients with heart failure: a comparison with healthy elders. J Cardiovasc Nurs. 2006;21:123\u20139.","journal-title":"J Cardiovasc Nurs"},{"key":"2506_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0002-9343(91)90007-K","volume":"91","author":"H Seligmann","year":"1991","unstructured":"Seligmann H, Halkin H, Rauchfleisch S, et al. Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med. 1991;91:151\u20135.","journal-title":"Am J Med"},{"key":"2506_CR25","first-page":"113","volume":"64","author":"P Pfitzenmeyer","year":"1994","unstructured":"Pfitzenmeyer P, Guilland JC, d\u2019Athis P, Petit-Marnier C, Gaudet M. Thiamine status of elderly patients with cardiac failure including the effects of supplementation. Int J Vitam Nutr Res. 1994;64:113\u20138.","journal-title":"Int J Vitam Nutr Res"},{"key":"2506_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0002-9343(99)80349-0","volume":"98","author":"I Shimon","year":"1995","unstructured":"Shimon I, Almog S, Vered Z, et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med. 1995;98:485\u201390.","journal-title":"Am J Med"},{"key":"2506_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ajem.2006.05.008","volume":"25","author":"HA Smithline","year":"2007","unstructured":"Smithline HA. Thiamine for the treatment of acute decompensated heart failure. Am J Emerg Med. 2007;25:124\u20136.","journal-title":"Am J Emerg Med"},{"issue":"3","key":"2506_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00392-011-0376-2","volume":"101","author":"Andreas W. Schoenenberger","year":"2011","unstructured":"Schoenenberger AW, Schoenenberger-Berzins R, der Maur CA, Suter PM, Vergopoulos A, Erne P. Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study. Clin Res Cardiol. 2012;101:159\u201364. \n                    https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22057652?dopt=Citation\n                    \n                  .","journal-title":"Clinical Research in Cardiology"},{"key":"2506_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/CCM.0000000000001572","volume":"44","author":"MW Donnino","year":"2016","unstructured":"Donnino MW, et al. Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study. Crit Care Med. 2016;44:360\u20137.","journal-title":"Crit Care Med"},{"key":"2506_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6904-12-4","volume":"12","author":"HA Smithline","year":"2012","unstructured":"Smithline HA, Donnino M, Greenblatt DJ. Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects. BMC Clin Pharmacol. 2012;12:4.","journal-title":"BMC Clin Pharmacol"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2506-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-019-2506-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2506-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T23:06:22Z","timestamp":1588633582000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-019-2506-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2506"],"URL":"https:\/\/doi.org\/10.1186\/s12906-019-2506-8","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,6]]},"assertion":[{"value":"29 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The human ethics committee of both hospitals approved this study. Specifically, this study was approved by the Institutional Review Board of the Human Research Protection Program at Baystate Medical Center, and the Institutional Review Board of the Human Subjects Protection Office at Beth Israel Deaconess Medical Center. All subjects consented to be in this study and signed approved consent documents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"96"}}